| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/27/2013 | CN102940889A Drug conjugate composition |
| 02/27/2013 | CN102940888A Targeted drug delivery method of pectin colon containing lecithin |
| 02/27/2013 | CN102940887A Solvent system for enhancing the solubility of pharmaceutical agents |
| 02/27/2013 | CN102940886A Biological barrier penetrating agent and preparation method thereof |
| 02/27/2013 | CN102940885A Method for improving efficiency of meso-porous silicon nano materials entering into cells by utilizing cationic liposome |
| 02/27/2013 | CN102940856A Method for preparing anti-viral oral liquid and product thereof |
| 02/27/2013 | CN102940813A Self-microemulsifying nanocombination comprising lucid ganoderma total triterpene and jobstears seed oil and preparation method and application thereof |
| 02/27/2013 | CN102940777A Cough relieving and sore-throat relieving cataplasm and preparation method thereof |
| 02/27/2013 | CN102940754A Rhizoma cyperi four-drug decoction transdermal patch and preparation method thereof |
| 02/27/2013 | CN102940688A Extraction method for polysaccharides and total flavonoids in fig leaves |
| 02/27/2013 | CN102940654A Ternary nano-micelle of flammulina velutipe non-saponification extracted sterol and preparation method thereof |
| 02/27/2013 | CN102940636A Injection of piperacillin-sulbactum sodium medicine composition and preparation method thereof |
| 02/27/2013 | CN102940630A Medicinal composition containing temsirolimus and preparation method of medicinal composition |
| 02/27/2013 | CN102940628A Compound amino acid injection and preparation method thereof |
| 02/27/2013 | CN102940623A Medicinal composition of levocarnitine compound |
| 02/27/2013 | CN102940610A Vitamin B6 composition freeze-drying orally disintegrating tablets and preparation method thereof |
| 02/27/2013 | CN102940609A Octreotide sustained-release microspheres with high encapsulation rate and preparation method thereof |
| 02/27/2013 | CN102940608A Tripterine controlled-release solid dispersion |
| 02/27/2013 | CN102940607A Injection of piperacillin-sulbactum sodium medicine composition injection and preparation method thereof |
| 02/27/2013 | CN102526745B Slow-release method for controlling medicine-carrying molecules of lyotopic liquid crystal by using micro electric field |
| 02/27/2013 | CN102379856B Omeprazole-containing enteric coated tablets |
| 02/27/2013 | CN102335144B Preparation method of poly (phenoxy) phosphazene microspheres |
| 02/27/2013 | CN102302450B Hydrophobic drug-albumin-glucan nano emulsion, as well as preparation method and application thereof |
| 02/27/2013 | CN102294033B Production process of spherical lactose particle |
| 02/27/2013 | CN102266282B Micro/nanometer fiber slow release preparation for treating cicatrices and preparation method thereof |
| 02/27/2013 | CN102260376B Novel cationic polymer used for non-virus type gene carrier, its preparation method and its purpose |
| 02/27/2013 | CN102258478B Animal pefloxacin mesylate pellets, and preparation method thereof |
| 02/27/2013 | CN102247600B Method for preparing diluent for pseudorabies live vaccine |
| 02/27/2013 | CN102228680B Thymosin phospholipids/bile salt compound micelle and preparation method and preparation thereof |
| 02/27/2013 | CN102228597B Medicament for treating oral ulcer and preparation method |
| 02/27/2013 | CN102204967B Preparation method for safflower care-free tablet |
| 02/27/2013 | CN102198117B Thermosensitive polymeric microcapsules and preparation method and use thereof |
| 02/27/2013 | CN102188363B Transdermal medicament delivery system containing donepezil compound, preparation and preparation method |
| 02/27/2013 | CN102161752B Process method for synthesizing medical biodegradable polylactic acid by polycondensation of lactic acid in presence of creatinine catalyst |
| 02/27/2013 | CN102160894B Benzamide analog mediated brain-targeting delivery system |
| 02/27/2013 | CN102145164B IAPP (Islet Amyloid Polypeptide) analog injection with better stability |
| 02/27/2013 | CN102145162B Injection of medicine for treating premature delivery |
| 02/27/2013 | CN102144981B Gemcitabine hydrochloride lyophilized powder injection and preparation method thereof |
| 02/27/2013 | CN101959532B Pharmaceutical composition for transnasal administration |
| 02/27/2013 | CN101947323B Gram negative bacterium vaccine and preparation method thereof |
| 02/27/2013 | CN101804034B Rabeprazole sodium powder injection and preparation method thereof |
| 02/27/2013 | CN101766657B Compound for activating immune cell and preparation method thereof |
| 02/27/2013 | CN101757631B Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration |
| 02/27/2013 | CN101687048B Hydrolysable polymeric FMOC- linker |
| 02/27/2013 | CN101632740B Chinese medicinal composition for regulating blood fat and improving sleeping and preparation method thereof |
| 02/27/2013 | CN101626762B Solvating system and sealant for medical use |
| 02/27/2013 | CN101461814B Medicament composition containing losartan and hydrochlorothiazidum |
| 02/27/2013 | CN101461810B Oral solid medicament composition containing lafutidine |
| 02/26/2013 | US8383767 Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain |
| 02/26/2013 | US8383758 Biodegradable polyketal polymers and methods for their formation and use |
| 02/26/2013 | US8383690 Pharmaceutical composition useful for the treatment of peptic ulcer diseases |
| 02/26/2013 | US8383689 Skin cosmetics comprising cocoon-shaped polymer fine particles |
| 02/26/2013 | US8383688 Products with water clusters |
| 02/26/2013 | US8383648 Applying such as 1-oxyl-4-(3'-ethoxy-2',2'-dimethyl)propanecarbonyloxy-2,2,6,6-tetramethylpiperidine to eye surface; halting growth, preventing surgery |
| 02/26/2013 | US8383611 Ciclesonide containing aqueous pharmaceutical composition |
| 02/26/2013 | US8383580 Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases |
| 02/26/2013 | US8383380 Segmented polymers and their conjugates |
| 02/26/2013 | US8383178 Treating fish oils with certain amines/amides to reduce oxidation |
| 02/26/2013 | US8383164 Antiviral composition and method for using the same |
| 02/26/2013 | US8383158 Methods and compositions to treat myocardial conditions |
| 02/26/2013 | US8383154 Swellable dosage form comprising gellan gum |
| 02/26/2013 | US8383147 Reinforced absorbable synthetic matrix for hemostatic applications |
| 02/26/2013 | US8383134 Biodegradable material based on opened starch |
| 02/26/2013 | US8383129 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 02/26/2013 | US8383117 CD44E tumor specific antibody |
| 02/26/2013 | US8383108 Therapeutic uses of monoclonal antibodies to the angiotensin-II type 1 receptor |
| 02/26/2013 | US8383091 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 02/26/2013 | CA2674885C Anti-ige vaccines |
| 02/26/2013 | CA2674837C Anti-ige vaccines |
| 02/26/2013 | CA2588943C Medical tape preparation |
| 02/26/2013 | CA2580659C Corticosteroid having low systemic absorption |
| 02/26/2013 | CA2537336C Multi-arm polymer prodrugs |
| 02/26/2013 | CA2358570C Protonated/acidified nucleic acids and methods of use |
| 02/26/2013 | CA2327586C Fap.alpha.-specific antibody with improved producibility |
| 02/26/2013 | CA2324648C Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 02/21/2013 | WO2013026015A1 Muc1 ligand traps for use in treating cancers |
| 02/21/2013 | WO2013025916A2 Dermal rejuvenation compositions and methods |
| 02/21/2013 | WO2013025545A2 Drug delivery systems and method of reducing foal infection by treating mares with gallium salts |
| 02/21/2013 | WO2013024710A1 Medicinal agent for evading immune response |
| 02/21/2013 | WO2013024663A1 Composition containing s-adenosyl-l-methionine with excellent storage stability |
| 02/21/2013 | WO2013024495A1 Pharmaceutical formulations of cabazitaxel |
| 02/21/2013 | WO2013024487A1 Anti- vitiligo composition |
| 02/21/2013 | WO2013024373A1 Pharmaceutical composition comprising cefuroxime |
| 02/21/2013 | WO2013024267A2 Novel compositions |
| 02/21/2013 | WO2013024070A1 Pharmaceutical aerosol product for administration by oral or nasal inhalation |
| 02/21/2013 | WO2013024053A1 Carrier-linked prodrugs having reversible carboxylic ester linkages |
| 02/21/2013 | WO2013024052A1 Carrier-linked treprostinil prodrugs |
| 02/21/2013 | WO2013024051A1 Sustained release composition of prostacyclin |
| 02/21/2013 | WO2013024049A1 Protein carrier-linked prodrugs |
| 02/21/2013 | WO2013024048A1 Polymeric hyperbranched carrier-linked prodrugs |
| 02/21/2013 | WO2013024047A1 High-loading water-soluble carrier-linked prodrugs |
| 02/21/2013 | WO2013024022A1 Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
| 02/21/2013 | WO2013024012A1 Medicinal skin protection composition with an active ingredient combination which improves the skin barrier |
| 02/21/2013 | WO2013000895A9 Dha and epa in the reduction of oxidative stress |
| 02/21/2013 | WO2012158624A3 Inhibitors of mitochondrial fission and methods of use thereof |
| 02/21/2013 | WO2012135517A3 Preparation of maytansinoid antibody conjugates by a one-step process |
| 02/21/2013 | WO2012116073A3 Amphiphilic dendron-coils, micelles thereof and uses |
| 02/21/2013 | WO2011101828A8 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and betamethasone, and a process to make it |
| 02/21/2013 | US20130046275 Material and method for treating internal cavities |
| 02/21/2013 | US20130046027 Chocolate with agglomerate structure and the method for preparing thereof |